Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
about
Gene expression patterns in ovarian carcinomasTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerQuantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cellsProteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma CellsSuppression of annexin A11 in ovarian cancer: implications in chemoresistance.Proteome study of colorectal carcinogenesis.Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry.Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinomaProteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα.Comparative proteomic and radiobiological analyses in human lung adenocarcinoma cells.Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arraysAnnexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathwaysIdentification of Annexin A4 as a hepatopancreas factor involved in liver cell survival.Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status.Comparative proteomics analysis of host cells infected with Brucella abortus A19.Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutationPharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer.Ovarian clear cell adenocarcinoma: a continuing enigmaPrognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancerMuscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis.Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment.Therapeutic resistance in lung cancer.Characterisation and protein expression profiling of annexins in colorectal cancer.Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.Targeting synuclein-gamma to counteract drug resistance in cancer.Biological modulation by lectins and their ligands in tumor progression and metastasis.Genomic analysis of epithelial ovarian cancer.Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients.Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers.An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line.Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma.The tumor suppressor annexin A10 is a novel component of nuclear paraspeckles.
P2860
Q24644996-326572CF-DCF9-46D8-ACDF-E14AD54E7F66Q28396304-E07A168B-7055-41B2-B9BD-FF08437F168CQ28478299-15918F04-B8C8-4407-B53F-AECB7BFAD283Q28550031-EF2BD1EB-D72B-4C66-9B65-2B760890A118Q30487754-7F519992-4767-486F-B97A-8DA2F64EAF65Q30724092-C806EF9A-78F6-4655-A51C-EFCA80F83E4EQ30863397-01EFAA53-0307-4CD8-AF9A-901B6105BF85Q30893374-1BAD3899-866E-4100-AA69-E232FC6EF655Q33850043-DBB03891-2E29-429F-98C9-E43D81717338Q33889579-C8A91A44-0E3D-4C62-B162-AE6373C2022AQ33984836-C31590E3-92E7-47BE-AD80-7F8FC3568743Q34412619-4799BF7A-F050-4055-A5F6-50A576A7FCF9Q34429251-68814D3F-33A8-493A-ADC5-1590B215E55BQ34496963-E5B67601-493A-4E15-88BB-72A3934F5356Q35040216-9DA4D545-C178-4D64-A2ED-AC8047941547Q35083284-7B8079A3-187C-4801-BB8B-E1BC2627604DQ35092488-1AC15E3B-73C6-4807-A1B9-6B56B69F3EC3Q35748034-A4A09C6C-0C2C-44A0-A483-873F0A43391CQ35863384-11A970D3-3DD1-4AE0-94BD-0AD39298F7BEQ36026090-C0E4458E-E8C7-45C7-B4A1-EFD5E2268AE3Q36073404-2241A0C4-1856-4812-9912-16999720B9F0Q36166133-3D60FBA4-BFDA-470C-8554-01304A496DEBQ36388185-6684C6EB-2AA8-4F33-B684-09D924E0E14BQ36609767-E1672609-5919-4B17-AD4A-22EC545ECB1AQ36614738-7BF31CD2-F4AA-4AC2-AF6C-4A0A90638E8EQ36727385-861085F9-2DFA-41E3-A10B-7CAE54EF65D0Q37030872-657F5453-945F-4FCE-9DCA-8B4FF004E5FBQ37065281-4B8D8553-0045-431A-B3FE-2B8CA5CA92C1Q37144104-7F654AC5-80B7-48DE-B868-12070CF92760Q37153741-CC55972C-0DA4-40B8-9473-4FBC219A740DQ37295775-505FE1BA-F06E-4CAC-9B84-04C97D043AD5Q37296914-42E1981A-8F76-4E5F-B5C0-2A7180637345Q37327379-6F3D2BBB-E491-471A-A24E-61229B459AA1Q37776738-ECAC6D89-A7E3-47C2-9F6C-CE8A77BA6E5AQ38183430-21266C2B-99CD-48EB-AB32-58E14A8ED765Q38625315-37ECC03B-E261-4BA5-AF50-337E4D55A07DQ39468037-E7CAD861-8EFF-444B-813F-D0B03E2CBA0AQ39737951-47C268D6-0360-4E3F-B438-CB2BC9C8C6C6Q39888581-40917C39-5286-41F3-B4E6-8659C6409685Q43442950-2D15B259-04FE-4068-A3F7-7F7384E30728
P2860
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@ast
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@en
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@nl
type
label
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@ast
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@en
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@nl
prefLabel
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@ast
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@en
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@nl
P2093
P2860
P3181
P356
P1476
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines
@en
P2093
P2860
P2888
P3181
P356
10.1054/BJOC.2000.1311
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1014211844